Literature DB >> 26034471

Pure laparoscopic hepatectomy combined with a pure laparoscopic pringle maneuver in patients with severe cirrhosis.

Shigehito Miyagi1, Chikashi Nakanishi1, Naoki Kawagishi1, Takashi Kamei1, Susumu Satomi1, Noriaki Ohuchi1.   

Abstract

Laparoscopic hepatectomy is a standard surgical procedure. However, it is difficult to perform in patients with severe cirrhosis because of fibrosis and a high risk of hemorrhage. We report our recent experience in five cases of pure laparoscopic hepatectomy combined with a pure laparoscopic Pringle maneuver in patients with severe cirrhosis. From 2012 to 2014, we performed pure laparoscopic partial hepatectomy in five patients with severe liver cirrhosis (indocyanine green retention rate at 15 min [ICG R15] >30% and fibrosis stage f4). A pure laparoscopic Pringle maneuver was employed in all patients. We investigated operative time, blood loss, duration of hospitalization and the days when discharge was possible, and compared these findings with those of patients with a normal liver (ICG R15 <10%, f0) who underwent pure laparoscopic partial hepatectomy during the same period (n = 7). As a result, operative time, blood loss, duration of hospitalization and the days when discharge was possible were similar in patients with cirrhosis undergoing pure laparoscopic hepatectomy combined with a pure laparoscopic Pringle maneuver to those in patients with a normal liver undergoing pure laparoscopic partial hepatectomy. In conclusion, pure laparoscopic hepatectomy combined with a pure laparoscopic Pringle maneuver appears to be safe in patients with severe cirrhosis.

Entities:  

Keywords:  Ascites; Liver cirrhosis; Pringle maneuver; Pure laparoscopic hepatectomy

Year:  2015        PMID: 26034471      PMCID: PMC4448045          DOI: 10.1159/000381394

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


Introduction

Radiofrequency ablation is a standard therapy for patients with hepatic tumors and severe liver cirrhosis who cannot tolerate more extensive surgery. However, this procedure has an important limitation: no tissue specimen is obtained from the tumor for pathological evaluation. Recently, pure laparoscopic partial hepatectomy has also become an accepted therapy for patients with severe cirrhosis. Pure laparoscopic hepatectomy is a less invasive procedure than conventional open hepatectomy or laparoscopic-assisted hepatectomy [1], and it provides tissue for pathological examination. However, in patients with severe liver cirrhosis, laparoscopic surgery is difficult to perform because of liver fibrosis and a high risk of hemorrhage [2, 3]. Pure laparoscopic hepatectomy minimizes both the destruction of collateral blood flow and lymphatic flow caused by laparotomy and limits hepatic mesenchymal injury caused by compression. This is especially beneficial for patients with liver cirrhosis. Therefore, pure laparoscopic hepatectomy lowers the risk of water or electrolyte imbalance and hypoproteinemia by reducing postoperative ascites production [2, 3]. However, the safety and potential contraindications for this procedure in patients with complete liver cirrhosis are poorly defined. Recently, we performed pure laparoscopic hepatectomy combined with a Pringle maneuver in five patients with severe cirrhosis (indocyanine green retention rate at 15 min [ICG R15] >30% and fibrosis stage f4) [4]. The purpose of this study was to investigate the safety of this procedure in patients with severe liver cirrhosis.

Case Report

Between 2012 and 2014 we performed pure laparoscopic partial hepatectomy combined with a Pringle maneuver in five patients with severe cirrhosis (ICG R15 >30%, f4) [4]. The pure laparoscopic Pringle maneuver was employed in all patients to reduce hemorrhage. We investigated operative time, blood loss, duration of hospitalization, and the days when discharge was possible, and compared these findings with those of patients with a normal liver (ICG R15 <10%, f0) who underwent pure laparoscopic partial hepatectomy during the same period (n = 7). The days when discharge was possible were granted when a drain and intravenous feeding were not necessary and any pain was under self-control. Patients were observed from the date of the operation until the last follow-up appointment. All values shown are mean ± standard deviation. Statistical analyses were conducted using the Mann-Whitney U test. All calculations were made using the JMP Pro software package (SAS Institute, Cary, N.C., USA). A p value <0.05 was considered statistically significant. All procedures were reviewed and approved by the Ethical Committee of Tohoku University Graduate School of Medicine and were performed in accordance with the ethical standards of the Declaration of Helsinki. As the result, no postoperative mortality or bleeding was observed. There were no surgical complications >grade IIIb according to the Clavien-Dindo classification. The patient characteristics are presented in table 1. The ICG R15 level was significantly higher in the severe liver cirrhosis cases than in the normal liver cases, but there were no other significant differences in patient characteristics between the two groups.
Table 1

Patient characteristics

Severe cirrhosis (n = 5)Normal liver (n = 7)
Age, years65.2±6.357.3±15.3
Sex ratio, M:F02:304:3
HCC: others05:003:4
Tumor size, mm22.0±8.224.1±18.6
ICG R1533.5±2.207.5±2.7*
Fibrosis stage, f0:f400:505:0
Child-Pugh score, A:B04:107:0

HCC = Hepatocellular carcinoma.

p < 0.05 vs. group I and group II.

The mean operative time in the severe liver cirrhosis cases (268.4 ± 86.5 min) was not significantly different from that in the normal liver cases (215.4 ± 77.0 min). The total mean bleeding volume was slightly higher in the severe liver cirrhosis cases (226.0 ± 203.8 ml) than in the normal liver cases (46.7 ± 62.9 ml), but the difference was not statistically significant. The total mean days of hospitalization were 7.4 ± 0.9 days in the severe liver cirrhosis cases and 7.0 ± 0.8 days in the normal liver cases; this difference was not statistically significant. The total mean days when discharge was possible were 4.0 ± 0.5 days in the severe liver cirrhosis cases and 4.6 ± 0.4 days in the normal liver cases; this difference was not statistically significant (table 2).
Table 2

Comparison of the two groups

Severe cirrhosis (n = 5)Normal liver (n = 7)
Operative time, min268.4±86.5215.4±77.0
Blood loss, ml226.0±203.8046.7±62.9
Hospitalization, days007.4±0.9007.0±0.8
Days when discharge was possible004.0±0.5004.6±0.4

Discussion

Pure laparoscopic partial hepatectomy is a minimally invasive procedure that has recently become useful in patients with severe cirrhosis. The advantages of this approach over radiofrequency ablation include the acquisition of tissue for pathological examination. Therefore, we investigated the safety and efficacy of pure laparoscopic partial hepatectomy combined with a pure laparoscopic Pringle maneuver in patients with severe liver cirrhosis. We found that there were no significant differences in any of the parameters investigated between patients with cirrhosis undergoing pure laparoscopic partial hepatectomy combined with a pure laparoscopic Pringle maneuver and patients with a normal liver undergoing laparoscopic partial hepatectomy. These findings indicate that pure laparoscopic partial hepatectomy combined with a pure laparoscopic Pringle maneuver is a safe surgical procedure for patients with severe cirrhosis. We believe that the key to this technique was the addition of the pure laparoscopic Pringle maneuver. Since this technique is performed laparoscopically, it allows the maintenance of abdominal cavity pressure. Because of this, the pure laparoscopic Pringle maneuver is an effective method in patients with severe cirrhosis for controlling not only arterial-portal bleeding, but also venous bleeding. In addition, maintaining abdominal pressure reduces lymphorrhea and ascites [5, 6]. Some investigators believe that the Pringle maneuver is not necessary, but we believe it enhances safety in emergencies, especially in patients with cirrhosis. Our study included a small number of patients; larger studies are necessary in the future. Our study has several limitations. In this study, we investigated only cases undergoing partial resection. We must assume that pure laparoscopic hepatectomy is safe and appropriate only in patients undergoing partial resection. However, we believe that pure laparoscopic hepatectomy is also safe in patients undergoing anatomical resection. During pure laparoscopic surgery, adequate patient positioning and port arrangement facilitates partial liver resection in the region of the subphrenic space, peri-inferior vena cava or retroperitoneum by providing a good visual field. In addition, the reduced formation of postoperative adhesions makes this procedure safer in the context of repeat hepatectomy procedures. Therefore, future studies should compare the results of partial resection and anatomical resection using this technique in patients with severe cirrhosis. With further studies, we may be able to determine whether pure laparoscopic hepatectomy can be safely used for anatomical resection. In conclusion, although pure laparoscopic partial hepatectomy for patients with severe cirrhosis may be difficult, complications were few when the Pringle laparoscopic maneuver was used. These results indicate that this combined technique is safe when used in patients with severe cirrhosis.

Disclosure Statement

The authors have no conflicts of interest to declare.
  6 in total

1.  Laparoscopic liver resection of hepatocellular carcinoma.

Authors:  Hironori Kaneko; Sumito Takagi; Yuichiro Otsuka; Masaru Tsuchiya; Akira Tamura; Toshio Katagiri; Tetsuya Maeda; Tadaaki Shiba
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

Review 2.  Pure laparoscopic hepatectomy for hepatocellular carcinoma with chronic liver disease.

Authors:  Zenichi Morise; Norihiko Kawabe; Jin Kawase; Hirokazu Tomishige; Hidetoshi Nagata; Hisanori Ohshima; Satoshi Arakawa; Rie Yoshida; Masashi Isetani
Journal:  World J Hepatol       Date:  2013-09-27

3.  Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.

Authors:  Qin-Song Sheng; Ren Lang; Qiang He; Yong-Jiu Yang; De-Fang Zhao; Da-Zhi Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-02

4.  Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients.

Authors:  Hironori Kaneko; Masaru Tsuchiya; Yuichiro Otsuka; Satoshi Yajima; Teruaki Minagawa; Masashi Watanabe; Akira Tamura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-05-21

5.  Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis.

Authors:  Akishige Kanazawa; Tadashi Tsukamoto; Sadatoshi Shimizu; Shintaro Kodai; Sadaaki Yamazoe; Satoshi Yamamoto; Shoji Kubo
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

6.  The comparison of oncologic and clinical outcomes of laparoscopic liver resection for hepatocellular carcinoma.

Authors:  Sung-Jin Kim; Hwa-Kyung Jung; Dong-Shik Lee; Sung-Su Yun; Hong-Jin Kim
Journal:  Ann Surg Treat Res       Date:  2014-01-22       Impact factor: 1.859

  6 in total
  2 in total

1.  Laparoscopic liver resection in cirrhotic patients with specific reference to a difficulty scoring system.

Authors:  Hiroki Uchida; Yukio Iwashita; Kazuhiro Tada; Kunihiro Saga; Hiroomi Takayama; Teijiro Hirashita; Yuichi Endo; Masayuki Ohta; Masafumi Inomata
Journal:  Langenbecks Arch Surg       Date:  2018-04-04       Impact factor: 3.445

2.  Effect of the intermittent Pringle maneuver on liver damage after hepatectomy: a retrospective cohort study.

Authors:  Xiaolin Wei; Wenjing Zheng; Zhiqing Yang; Hui Liu; Tengqian Tang; Xiaowu Li; Xiangde Liu
Journal:  World J Surg Oncol       Date:  2019-08-13       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.